On the other hand, serving as the central mediator of TGF-β signaling pathway, SMAD4 is a potential prognostic marker of breast carcinoma development, and it is critical for stem cells’ self-renewal (Liu et al., 2014). Here, SMAD4 is linked to breast carcinoma.